RET gene mutations and polymorphisms in medullary thyroid carcinomas in Indian patients. (Q54353008)

28 May 2018

title

RET gene mutations and polymorphisms in medullary thyroid carcinomas in Indian patients. (English)

1 reference

28 May 2018

0 references

B P Sharma

1

1 reference

28 May 2018

D Saranath

series ordinal

2

1 reference

28 May 2018

publication date

1 September 2011

1 reference

28 May 2018

published in

Journal of Biosciences

1 reference

28 May 2018

volume

36

1 reference

28 May 2018

issue

4

1 reference

28 May 2018

page(s)

603-611

1 reference

28 May 2018

https://scigraph.springernature.com/pub.10.1007/s12038-011-9095-0

exact match

0 references

cites work

Polymorphisms in exon 13 and intron 14 of the RET protooncogene: genetic modifiers of medullary thyroid carcinoma?

1 reference

https://api.crossref.org/works/10.1007%2FS12038-011-9095-0

Genetic abnormalities detected in ependymomas by comparative genomic hybridisation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12038-011-9095-0

RET polymorphisms and sporadic medullary thyroid carcinoma in a Portuguese population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12038-011-9095-0

RET as a diagnostic and therapeutic target in sporadic and hereditary endocrine tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12038-011-9095-0

Seminars in medicine of the Beth Israel Hospital, Boston. The RET proto-oncogene in multiple endocrine neoplasia type 2 and Hirschsprung's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12038-011-9095-0

RET proto-oncogene in the development of human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12038-011-9095-0

The relationship between specific RET proto-oncogene mutations and disease phenotype in multiple endocrine neoplasia type 2. International RET mutation consortium analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12038-011-9095-0

Analysis of inherited genetic variants in ret proto-oncogene of Brazilian patients with apparently sporadic medullary thyroid carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12038-011-9095-0

Screening of six risk exons of the RET proto-oncogene in families with medullary thyroid carcinoma in the Czech Republic.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12038-011-9095-0

Genotype-phenotype correlations in Hungarian patients with hereditary medullary thyroid cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12038-011-9095-0

The genetic basis of hereditary medullary thyroid cancer: clinical implications for the surgeon, with a particular emphasis on the role of prophylactic thyroidectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12038-011-9095-0

Hereditary cancer predisposition in children: genetic basis and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12038-011-9095-0

The influence of gender, age, and RET polymorphisms on C-cell hyperplasia and medullary thyroid carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12038-011-9095-0

A single-nucleotide polymorphic variant of the RET proto-oncogene is underrepresented in sporadic Hirschsprung disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12038-011-9095-0

The phenotypes associated with ret mutations in the multiple endocrine neoplasia type 2 syndrome.

21 January 2018

1 reference

12 December 2020

RET oncogene mutations in 75 cases of familial medullary thyroid carcinoma in Japan

1 reference

12 December 2020

Genotype‐phenotype correlation in multiple endocrine neoplasia type 2: report of the International RET Mutation Consortium

1 reference

12 December 2020

Molecular genetic diagnostic program of multiple endocrine neoplasia type 2A and familial medullary thyroid carcinoma syndromes in Hungary

1 reference

12 December 2020

Evaluation of the role of RET polymorphisms/haplotypes as modifier loci for MEN 2, and analysis of the correlation with the type of RET mutation in a series of Spanish patients

1 reference

12 December 2020

Presymptomatic DNA screening in families with multiple endocrine neoplasia type 2 and familial medullary thyroid carcinoma

1 reference

12 December 2020

Association of RET codon 691 polymorphism in radiation-induced human thyroid tumours with C-cell hyperplasia in peritumoural tissue

1 reference

12 December 2020

RET mutation status in medullary thyroid cancer(MTC) patients and the significance of genetic screening for mutations in their immediate relatives--a preliminary report

1 reference

12 December 2020

Hereditary medullary thyroid cancer in Slovenia--genotype-phenotype correlations.

1 reference

12 December 2020

Significance of the RET proto-oncogene polymorphisms in Turkish sporadic medullary thyroid carcinoma patients

1 reference

12 December 2020

Polymorphisms in the RET proto-oncogene and the phenotypic presentation of familial medullary thyroid carcinoma

1 reference

12 December 2020

High prevalence of the C634Y mutation in the RET proto-oncogene in MEN 2A families in Spain

1 reference

12 December 2020

A study of histopathological features of medullary carcinoma of the thyroid: cases from a single institute in India.

1 reference

12 December 2020

A unique RET EXON 11 (G691S) polymorphism in an Indian patient with a collision tumor of the thyroid

1 reference

12 December 2020

10.1007/S12038-011-9095-0

Identifiers

DOI

1 reference

28 May 2018

1 reference

28 May 2018